![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia
Hengyou Weng, Feng Huang, Zhaojin Yu, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1566-1582.e10
Open Access | Times Cited: 156
Hengyou Weng, Feng Huang, Zhaojin Yu, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1566-1582.e10
Open Access | Times Cited: 156
Showing 1-25 of 156 citing articles:
The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 136
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 136
METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism
Li Han, Lei Dong, Keith Leung, et al.
Cell stem cell (2023) Vol. 30, Iss. 1, pp. 52-68.e13
Open Access | Times Cited: 72
Li Han, Lei Dong, Keith Leung, et al.
Cell stem cell (2023) Vol. 30, Iss. 1, pp. 52-68.e13
Open Access | Times Cited: 72
N6-methyladenosine-mediated gene regulation and therapeutic implications
Yujiao Liu, Dan Yang, Tao Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 454-467
Closed Access | Times Cited: 52
Yujiao Liu, Dan Yang, Tao Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 454-467
Closed Access | Times Cited: 52
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 41
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 41
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 31
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 31
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and NRF2/GPX4 Axes
Lixian Ding, Shuwei Dang, Mingjun Sun, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 150-163
Closed Access | Times Cited: 17
Lixian Ding, Shuwei Dang, Mingjun Sun, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 150-163
Closed Access | Times Cited: 17
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis
Yongqiang Zhou, Jiexi Yan, He Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 14
Yongqiang Zhou, Jiexi Yan, He Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 14
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 12
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 12
METTL3‐mediated N6‐methyladenosine exacerbates ferroptosis via m6A‐IGF2BP2‐dependent mitochondrial metabolic reprogramming in sepsis‐induced acute lung injury
Hao Zhang, Dan Wu, Yanghanzhao Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 9
Open Access | Times Cited: 34
Hao Zhang, Dan Wu, Yanghanzhao Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 9
Open Access | Times Cited: 34
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 33
m6A modification in inflammatory bowel disease provides new insights into clinical applications
Jiamin Zhang, Bimei Song, Yue Zeng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114298-114298
Open Access | Times Cited: 21
Jiamin Zhang, Bimei Song, Yue Zeng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114298-114298
Open Access | Times Cited: 21
Roles and implications of mRNA N6‐methyladenosine in cancer
Lingxing Zeng, Xudong Huang, Jialiang Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 729-748
Open Access | Times Cited: 20
Lingxing Zeng, Xudong Huang, Jialiang Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 729-748
Open Access | Times Cited: 20
The rise of epitranscriptomics: recent developments and future directions
Jonas Cerneckis, Guo‐li Ming, Hongjun Song, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 24-38
Open Access | Times Cited: 20
Jonas Cerneckis, Guo‐li Ming, Hongjun Song, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 24-38
Open Access | Times Cited: 20
IGF2BP2-m6A-circMMP9 axis recruits ETS1 to promote TRIM59 transcription in laryngeal squamous cell carcinoma
Jinling Li, Huan Cao, Jianwang Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Jinling Li, Huan Cao, Jianwang Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma
Hongshi Cai, Jianfeng Liang, Yaoqi Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Hongshi Cai, Jianfeng Liang, Yaoqi Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
m6A‐dependent upregulation of DDX21 by super‐enhancer‐driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia
Yanchun Zhao, Yutong Zhou, Qian Yu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 7
Yanchun Zhao, Yutong Zhou, Qian Yu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 7
Comprehensive review of amino acid transporters as therapeutic targets
Ran Xia, Hai-Feng Peng, Xing Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129646-129646
Closed Access | Times Cited: 6
Ran Xia, Hai-Feng Peng, Xing Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129646-129646
Closed Access | Times Cited: 6
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Genetic variations in IGF2BP2 and CAPN10 and their interaction with environmental factors increase gestational diabetes mellitus risk in Chinese women
Runqiu Yang, Xin Wang, Yi Zhang, et al.
Gene (2025), pp. 149226-149226
Closed Access
Runqiu Yang, Xin Wang, Yi Zhang, et al.
Gene (2025), pp. 149226-149226
Closed Access
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Helicobacter pylori reduces METTL14-mediated VAMP3 m6A modification and promotes the development of gastric cancer by regulating LC3C-mediated c-Met recycling
Xixi Cui, Mingjie Chang, Yuqiong Wang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Xixi Cui, Mingjie Chang, Yuqiong Wang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
A novel perspective on survival prediction for AML patients: integration of machine learning in SEER database applications
Zheng-yi Jia, Maierbiya Abulimiti, Wu Yun, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e42030-e42030
Open Access
Zheng-yi Jia, Maierbiya Abulimiti, Wu Yun, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e42030-e42030
Open Access